125 related articles for article (PubMed ID: 6256120)
1. Converting enzyme inhibition during chronic angiotensin II infusion in rats: evidence against a non-angiotensin mechanism.
Textor SC; Brunner HR; Gavras H
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():71s-74s. PubMed ID: 6256120
[TBL] [Abstract][Full Text] [Related]
2. Converting enzyme inhibition during chronic angiotensin II infusion in rats. Evidence against a nonangiotensin mechanism.
Textor SC; Brunner HR; Gavras H
Hypertension; 1981; 3(2):269-76. PubMed ID: 6260647
[TBL] [Abstract][Full Text] [Related]
3. Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat.
Marks ES; Bing RF; Thurston H; Swales JD
Clin Sci (Lond); 1980 Jan; 58(1):1-6. PubMed ID: 6986224
[TBL] [Abstract][Full Text] [Related]
4. The opposing effects of chronic angiotensin-converting enzyme blockade by captopril on the responses to exogenous angiotensin II and vasopressin vs. norepinephrine in rats.
Spertini F; Brunner HR; Waeber B; Gavras H
Circ Res; 1981 May; 48(5):612-8. PubMed ID: 6260396
[TBL] [Abstract][Full Text] [Related]
5. Resistance to blockade by saralasin of effect of ACE inhibitors in conscious sodium-restricted dog.
Zimmerman BG; Goering JL; Raich PC
Am J Physiol; 1988 Nov; 255(5 Pt 2):F944-52. PubMed ID: 2847552
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of captopril on regional haemodynamic responses to angiotensin I and bradykinin in conscious rats.
Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1993 Mar; 108(3):769-75. PubMed ID: 8467363
[TBL] [Abstract][Full Text] [Related]
7. Converting enzyme inhibition and modulation of plasma renin activity with captopril in anesthetized rats.
Suzuki M; Satoh S
Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):121-36. PubMed ID: 6275810
[TBL] [Abstract][Full Text] [Related]
8. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.
McCaa RE
Prog Biochem Pharmacol; 1980; 17():29-35. PubMed ID: 7010367
[TBL] [Abstract][Full Text] [Related]
9. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
10. Converting enzyme inhibition with captopril abolishes sympathoexcitation to euglycemic hyperinsulinemia in rats.
Muntzel MS; Morales J; Akinsefunmi A
Am J Hypertens; 2001 Jun; 14(6 Pt 1):592-8. PubMed ID: 11411741
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
[TBL] [Abstract][Full Text] [Related]
12. Lack of a role of circulating bradykinin in the blood pressure response to acute angiotensin converting enzyme inhibition in rats.
Aubert JF; Waeber B; Nussberger J; Vavrek R; Stewart JM; Brunner HR
Agents Actions Suppl; 1987; 22():349-54. PubMed ID: 3324717
[TBL] [Abstract][Full Text] [Related]
13. Effect of the converting-enzyme inhibitor SQ 14 225 (captopril) in early one-kidney, one-clip hypertension in the rat.
Vandongen R; Tunney A; Martinez P
Clin Sci (Lond); 1981 Apr; 60(4):387-92. PubMed ID: 7018794
[TBL] [Abstract][Full Text] [Related]
14. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of depressor responses to arachidonic acid by angiotensin converting enzyme inhibitors in the rat.
Hui SC; Dai S; Ogle CW
Clin Exp Pharmacol Physiol; 1984; 11(6):621-5. PubMed ID: 6100239
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
[TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with quercetin does not inhibit angiotensin-converting enzyme in vivo or in vitro.
Neto-Neves EM; Montenegro MF; Dias-Junior CA; Spiller F; Kanashiro A; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):825-9. PubMed ID: 20406213
[TBL] [Abstract][Full Text] [Related]
18. The effect of captopril on the reflex control heart rate: possible mechanisms.
Ajayi AA; Campbell BC; Meredith PA; Kelman AW; Reid JL
Br J Clin Pharmacol; 1985 Jul; 20(1):17-25. PubMed ID: 2992561
[TBL] [Abstract][Full Text] [Related]
19. Hormonal responses to angiotensin blockade. Comparison between receptor antagonism and converting enzyme inhibition.
Johnston CI; Millar JA; Casley DJ; McGrath BP; Matthews PG
Circ Res; 1980 Jun; 46(6 Pt 2):I128-34. PubMed ID: 6247084
[No Abstract] [Full Text] [Related]
20. Angiotensin-(1-7) antagonist A-779 attenuates the potentiation of bradykinin by captopril in rats.
Maia LG; Ramos MC; Fernandes L; de Carvalho MH; Campagnole-Santos MJ; Souza dos Santos RA
J Cardiovasc Pharmacol; 2004 May; 43(5):685-91. PubMed ID: 15071356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
